Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionNew York State Common Retirement Fund
Latest Disclosed Ownership293,357 shares
Latest Disclosed Value $ 8,715,636
New York State Common Retirement Fund reports 17.55% increase in ownership of TVTX / Travere Therapeutics, Inc.

On May 6, 2026 - New York State Common Retirement Fund filed a 13F-HR form disclosing ownership of 293,357 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $8,715,636 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 249,557 shares of Travere Therapeutics, Inc.. This represents a change in shares of 17.55% during the quarter. The current value of the position is $13,259,736 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 293,357 43,800 17.55 8,716 -8.60 0.0122
2026-02-12 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 249,557 221,743 797.24 9,536 1,335.99 0.0127
2025-11-03 2025-09-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 27,814 0 0.00 665 61.56 0.0009
2025-10-08 2025-06-30 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 27,814 4,900 21.38 412 0.24 0.0005
2025-08-13 2025-06-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 27,814 4,900 0 0.0005
2025-10-08 2025-03-31 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 22,914 0 0.00 411 2.76 0.0006
2025-05-01 2025-03-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 22,914 0 0 0.0006
2025-10-08 2024-12-31 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 22,914 0 0.00 399 24.69 0.0005
2025-01-31 2024-12-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 22,914 0 0 0.0005
2025-10-08 2024-09-30 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 22,914 -2,700 -10.54 321 52.38 0.0004
2024-10-28 2024-09-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 22,914 -2,700 0 0.0004
2025-10-08 2024-06-30 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 25,614 23 0.09 211 6.60 0.0003
2024-07-31 2024-06-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 25,614 23 0 0.0003
2025-10-08 2024-03-31 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 25,591 -71 -0.28 197 -14.35 0.0003
2024-05-07 2024-03-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 25,591 -71 0 0.0003
2025-10-08 2023-12-31 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 25,662 -106 -0.41 231 0.00 0.0003
2024-02-01 2023-12-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 25,662 -106 0 0.0003
2025-10-08 2023-09-30 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 25,768 -27,103 -51.26 230 -71.67 0.0003
2023-11-07 2023-09-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 25,768 -27,103 0 0.0003
2025-10-08 2023-06-30 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 52,871 -6,860 -11.48 812 -39.54 0.0010
2023-08-07 2023-06-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 52,871 -6,860 1 0.0010
2025-10-08 2023-03-31 13F/A-2 TRAVERE THERAPEUTICS Common Stock 89422G107 59,731 1,780 3.07 1,343 10.26 0.0018
2023-05-18 2023-03-31 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 59,731 1,780 1 0.0018
2023-05-02 2023-03-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 59,731 1,780 1 0.0018
2025-10-08 2022-12-31 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 57,951 -26 -0.04 1,219 -14.77 0.0017
2023-01-30 2022-12-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 57,951 -26 1 0.0017
2022-11-08 2022-09-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 57,977 14,759 34.15 1,429 36.49 0.0021
2022-08-04 2022-06-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 43,218 -121 -0.28 1,047 -6.27 0.0014
2022-07-01 2022-03-31 13F/A-1 TRAVERE THERAPEUTICS Common Stock 89422G107 43,339 55 0.13 1,117 -16.89 0.0012
2022-05-05 2022-03-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 43,339 55 1,117 0.0012
2022-02-02 2021-12-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 43,284 3,945 10.03 1,344 40.88 0.0013
2021-11-02 2021-09-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 39,339 -11,315 -22.34 954 29.09 0.0010
2021-08-02 2021-06-30 13F TRAVERE THERAPEUTICS Common Stock 89422G107 50,654 4,354 9.40 739 -36.07 0.0008
2021-05-11 2021-03-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 46,300 0 0.00 1,156 -8.40 0.0013
2021-02-08 2020-12-31 13F TRAVERE THERAPEUTICS Common Stock 89422G107 46,300 5,500 13.48 1,262 67.60 0.0014
2020-11-05 2020-09-30 13F RETROPHIN Common Stock 761299106 40,800 0 0.00 753 -9.60 0.0009
2020-08-07 2020-06-30 13F RETROPHIN Common Stock 761299106 40,800 5,100 14.29 833 59.88 0.0011
2020-05-06 2020-03-31 13F RETROPHIN Common Stock 761299106 35,700 0 0.00 521 2.76 0.0008
2020-02-05 2019-12-31 13F RETROPHIN Common Stock 761299106 35,700 -9,000 -20.13 507 -2.12 0.0006
2019-11-07 2019-09-30 13F RETROPHIN Common Stock 761299106 44,700 0 0.00 518 -42.32 0.0007
2019-08-09 2019-06-30 13F RETROPHIN Common Stock 761299106 44,700 5,000 12.59 898 0.00 0.0011
2019-05-08 2019-03-31 13F RETROPHIN Common Stock 761299106 39,700 0 0.00 898 0.00 0.0012
2019-02-08 2018-12-31 13F RETROPHIN Common Stock 761299106 39,700 -4,800 -10.79 898 -29.73 0.0013
2018-11-07 2018-09-30 13F RETROPHIN Common Stock 761299106 44,500 0 0.00 1,278 5.36 0.0015
2018-08-10 2018-06-30 13F RETROPHIN Common Stock 761299106 44,500 0 0.00 1,213 21.91 0.0015
2018-05-10 2018-03-31 13F RETROPHIN Common Stock 761299106 44,500 3,600 8.80 995 15.43 0.0012
2018-02-13 2017-12-31 13F RETROPHIN Common Stock 761299106 40,900 0 0.00 862 -15.32 0.0010
2017-11-06 2017-09-30 13F RETROPHIN Common Stock 761299106 40,900 0 0.00 1,018 28.37 0.0013
2017-08-11 2017-06-30 13F RETROPHIN Common Stock 761299106 40,900 -1 -0.00 793 5.03 0.0010
2017-05-15 2017-03-31 13F RETROPHIN Common Stock 761299106 40,901 1 0.00 755 -2.45 0.0010
2017-02-13 2016-12-31 13F RETROPHIN Common Stock 761299106 40,900 0 0.00 774 -15.41 0.0011
2016-11-08 2016-09-30 13F RETROPHIN Common Stock 761299106 40,900 6,900 20.29 915 50.99 0.0013
2016-08-10 2016-06-30 13F RETROPHIN Common Stock 761299106 34,000 0 0.00 606 30.60 0.0009
2016-05-06 2016-03-31 13F RETROPHIN Common Stock 761299106 34,000 0 0.00 464 -29.27 0.0007
2016-02-05 2015-12-31 13F RETROPHIN Common Stock 761299106 34,000 0 0.00 656 -4.79 0.0010
2015-11-12 2015-09-30 13F RETROPHIN Common Stock 761299106 34,000 689 2.07 689 -37.59 0.0011
2015-08-11 2015-06-30 13F RETROPHIN Common Stock 761299106 33,311 33,311 1,104 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.